Three Functional Areas to Accelerate Technology Translation
1. Biolocity U
2. Biolocity Fund
Funding is available for biomedical technologies from partner institutes (Emory University and Georgia Institute of Technology). Eligible technology must positively impact human health with compelling evidence of commercial potential. Ideal technologies and therapeutics will have preliminary proof of concept data and a clear path to private sector translation. Additionally, as part of the BARDA DRIVe network, Biolocity can connect health security technologies with funding and resources for development.
A key part of the Biolocity funding application process is the in-depth market diligence created for each technology. Using industry best practices and venture capital methodology, we identify each project’s commercial potential and recommend the appropriate commercialization model. Applicants that are not selected for final funding still benefit from this research and receive a copy of the diligence reports created for their technologies.
Technologies selected for funding receive active project management and mentorship to assist in meeting the commercialization milestones created during the application process. Awardees attend bi-weekly meetings which offer the opportunity to meet with consultants on project specific goals to accelerate their technology development.
Formalized coordination with the biotechnology commercialization ecosystem provides awardees with access to resources including incubators, accelerators, and connection with entrepreneurial talent. These efforts combined help lower barriers to translation of academic technology to the private sector.